Sub-Item 77O (1)

STRATEGIC FUNDS, INC.

-DREYFUS SELECT MANAGERS SMALL CAP GROWTH FUND

On October 6, 2015, Dreyfus Select Managers Small Cap Growth Fund (the "Fund"), a series of Strategic Funds, Inc., purchased 6,694 shares of Common Stock issued by Sarepta Therapeutics, Inc. (CUSIP No. 803607100) (the "Shares") at a purchase price of  $39.00 per Share, including underwriter compensation of 0.05%.  The Shares were purchased from Credit Suisse Securities (USA) LLC, a member of the underwriting syndicate of which Roth Capital Partners, LLC, an affiliate of the Fund's investment adviser, was also a member.  Roth Capital Partners, LLC received no benefit in connection with the transaction.  The following is a list of the syndicate's members:

Credit Suisse Securities (USA) LLC

Morgan Stanley & Co. LLC

Needham & Company LLC

Oppenheimer & Co. Inc.

Robert W. Baird & Co. Incorporated

Roth Capital Partners, LLC

William Blair & Co. LLC

Accompanying this statement are materials provided to the Board of Directors for the Fund, which ratified the purchase as being in compliance with the Fund's Rule 10f-3 Procedures at a Board meeting held on February 29, 2016.  These materials include additional information about the terms of the transaction.